216 related articles for article (PubMed ID: 33373040)
61. Invasive fibroblasts: fundamental difference between sporadic inclusion body myositis and polymyositis.
Doppler K; Pantazis G; Mack A; Bornemann A
Muscle Nerve; 2014 Feb; 49(2):175-80. PubMed ID: 23649793
[TBL] [Abstract][Full Text] [Related]
62. The association of sporadic inclusion body myositis and Sjögren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype.
Rojana-udomsart A; Needham M; Luo YB; Fabian V; Walters S; Zilko PJ; Mastaglia FL
Clin Neurol Neurosurg; 2011 Sep; 113(7):559-63. PubMed ID: 21507567
[TBL] [Abstract][Full Text] [Related]
63. Sporadic inclusion body myositis: A review of recent clinical advances and current approaches to diagnosis and treatment.
Needham M; Mastaglia FL
Clin Neurophysiol; 2016 Mar; 127(3):1764-73. PubMed ID: 26778717
[TBL] [Abstract][Full Text] [Related]
64. Neuropathy in sporadic inclusion body myositis: A multi-modality neurophysiological study.
Lee JH; Boland-Freitas R; Liang C; Howells J; Ng K
Clin Neurophysiol; 2020 Nov; 131(11):2766-2776. PubMed ID: 32928695
[TBL] [Abstract][Full Text] [Related]
65. Mitochondrial DNA depletion in sporadic inclusion body myositis.
Bhatt PS; Tzoulis C; Balafkan N; Miletic H; Tran GTT; Sanaker PS; Bindoff LA
Neuromuscul Disord; 2019 Mar; 29(3):242-246. PubMed ID: 30850168
[TBL] [Abstract][Full Text] [Related]
66. Demographic features of Japanese patients with sporadic inclusion body myositis: a single-center referral experience.
Nakanishi H; Koike H; Matsuo K; Tanaka F; Noda T; Fujikake A; Kimura S; Katsuno M; Doyu M; Watanabe H; Sobue G
Intern Med; 2013; 52(3):333-7. PubMed ID: 23370740
[TBL] [Abstract][Full Text] [Related]
67. Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken.
Benveniste O; Stenzel W; Hilton-Jones D; Sandri M; Boyer O; van Engelen BG
Acta Neuropathol; 2015 May; 129(5):611-24. PubMed ID: 25579751
[TBL] [Abstract][Full Text] [Related]
68. Sporadic inclusion body myositis: new insights and potential therapy.
Machado PM; Dimachkie MM; Barohn RJ
Curr Opin Neurol; 2014 Oct; 27(5):591-8. PubMed ID: 25159931
[TBL] [Abstract][Full Text] [Related]
69. Th1 response and systemic treg deficiency in inclusion body myositis.
Allenbach Y; Chaara W; Rosenzwajg M; Six A; Prevel N; Mingozzi F; Wanschitz J; Musset L; Charuel JL; Eymard B; Salomon B; Duyckaerts C; Maisonobe T; Dubourg O; Herson S; Klatzmann D; Benveniste O
PLoS One; 2014; 9(3):e88788. PubMed ID: 24594700
[TBL] [Abstract][Full Text] [Related]
70. [Sporadic inclusion body myositis in Japan].
Aoki M; Suzuki N
Nihon Rinsho; 2012 May; 70(5):895-906. PubMed ID: 22620019
[TBL] [Abstract][Full Text] [Related]
71. Morphological and molecular comparison of HIV-associated and sporadic inclusion body myositis.
Vogt S; Kleefeld F; Preusse C; Arendt G; Bieneck S; Brunn A; Deckert M; Englert B; Goebel HH; Masuhr A; Neuen-Jacob E; Kornblum C; Reimann J; Montagnese F; Schoser B; Stenzel W; Hahn K
J Neurol; 2023 Sep; 270(9):4434-4443. PubMed ID: 37280376
[TBL] [Abstract][Full Text] [Related]
72. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
[TBL] [Abstract][Full Text] [Related]
73. Clinical implication of denervation in sporadic inclusion body myositis.
Noda S; Murakami A; Kazuta T; Hirano S; Kimura S; Nakanishi H; Matsuo K; Tsujikawa K; Yamada S; Iida M; Koike H; Kuru S; Katsuno M
J Neurol Sci; 2022 Aug; 439():120317. PubMed ID: 35709642
[TBL] [Abstract][Full Text] [Related]
74. Treatment of sporadic inclusion body myositis with bimagrumab.
Amato AA; Sivakumar K; Goyal N; David WS; Salajegheh M; Praestgaard J; Lach-Trifilieff E; Trendelenburg AU; Laurent D; Glass DJ; Roubenoff R; Tseng BS; Greenberg SA
Neurology; 2014 Dec; 83(24):2239-46. PubMed ID: 25381300
[TBL] [Abstract][Full Text] [Related]
75. Myositis with prominent B cell aggregates may meet classification criteria for sporadic inclusion body myositis.
Meyer A; Troyanov Y; Korathanakhun P; Landon-Cardinal O; Leclair V; Allard-Chamard H; Bourré-Tessier J; Makhzoum JP; Isabelle C; Larue S; Grand'Maison F; Massie R; Page ML; Mansour AM; Routhier N; Zarka F; Roy F; Sonnen J; Satoh M; Fritzler M; Hudson M; Senécal JL; Karamchandani J; Ellezam B; O'Ferrall E
Neuromuscul Disord; 2023 Feb; 33(2):169-182. PubMed ID: 36649672
[TBL] [Abstract][Full Text] [Related]
76. Mortality and Causes of Death in Patients with Sporadic Inclusion Body Myositis: Survey Study Based on the Clinical Experience of Specialists in Australia, Europe and the USA.
Price MA; Barghout V; Benveniste O; Christopher-Stine L; Corbett A; de Visser M; Hilton-Jones D; Kissel JT; Lloyd TE; Lundberg IE; Mastaglia F; Mozaffar T; Needham M; Schmidt J; Sivakumar K; DeMuro C; Tseng BS
J Neuromuscul Dis; 2016 Mar; 3(1):67-75. PubMed ID: 27854208
[TBL] [Abstract][Full Text] [Related]
77. Sporadic Inclusion Body Myositis Manifesting as Isolated Muscle Weakness of the Finger Flexors Three Years after Disease Onset.
Suwa Y; Suzuki N; Soga T; Harada R; Shibui A; Kuroda H; Izumi R; Tateyama M; Nakashima I; Sonoo M; Aoki M
Intern Med; 2016; 55(23):3521-3524. PubMed ID: 27904121
[TBL] [Abstract][Full Text] [Related]
78. [Inclusion body myositis].
Suzuki N; Aoki M
Brain Nerve; 2011 Nov; 63(11):1205-15. PubMed ID: 22068473
[TBL] [Abstract][Full Text] [Related]
79. Epidemiology and Natural History of Inclusion Body Myositis: A 40-Year Population-Based Study.
Shelly S; Mielke MM; Mandrekar J; Milone M; Ernste FC; Naddaf E; Liewluck T
Neurology; 2021 May; 96(21):e2653-e2661. PubMed ID: 33879596
[TBL] [Abstract][Full Text] [Related]
80. Abnormal distribution of heterogeneous nuclear ribonucleoproteins in sporadic inclusion body myositis.
Pinkus JL; Amato AA; Taylor JP; Greenberg SA
Neuromuscul Disord; 2014 Jul; 24(7):611-6. PubMed ID: 24857366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
